Literature DB >> 18978023

IMGT, the international ImMunoGeneTics information system.

Marie-Paule Lefranc1, Véronique Giudicelli, Chantal Ginestoux, Joumana Jabado-Michaloud, Géraldine Folch, Fatena Bellahcene, Yan Wu, Elodie Gemrot, Xavier Brochet, Jérôme Lane, Laetitia Regnier, François Ehrenmann, Gérard Lefranc, Patrice Duroux.   

Abstract

IMGT, the international ImMunoGeneTics information system (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc, Laboratoire d'ImmunoGénétique Moléculaire LIGM (Université Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and manage the complexity of immunogenetics data. The building of a unique ontology, IMGT-ONTOLOGY, has made IMGT the global reference in immunogenetics and immunoinformatics. IMGT is a high-quality integrated knowledge resource specialized in the immunoglobulins or antibodies, T cell receptors, major histocompatibility complex, of human and other vertebrate species, proteins of the IgSF and MhcSF, and related proteins of the immune systems of any species. IMGT provides a common access to standardized data from genome, proteome, genetics and 3D structures. IMGT consists of five databases (IMGT/LIGM-DB, IMGT/GENE-DB, IMGT/3Dstructure-DB, etc.), fifteen interactive online tools for sequence, genome and 3D structure analysis, and more than 10,000 HTML pages of synthesis and knowledge. IMGT is used in medical research (autoimmune diseases, infectious diseases, AIDS, leukemias, lymphomas and myelomas), veterinary research, biotechnology related to antibody engineering (phage displays, combinatorial libraries, chimeric, humanized and human antibodies), diagnostics (clonalities, detection and follow-up of residual diseases) and therapeutical approaches (graft, immunotherapy, vaccinology). IMGT is freely available at http://www.imgt.org.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978023      PMCID: PMC2686541          DOI: 10.1093/nar/gkn838

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

The number of genomics, genetics, 3D and functional data published in the immunogenetics field is growing exponentially and involves fundamental, clinical, veterinary, and pharmaceutical research. The number of potential protein forms of the antigen receptors, immunoglobulins (IG) and T cell receptors (TR) is almost unlimited. The potential repertoire of each individual is estimated to comprise about 1012 different IG (or antibodies) and TR, and the limiting factor is only the number of B and T cells that an organism is genetically programmed to produce. This huge diversity is inherent to the particularly complex and unique molecular synthesis and genetics of the antigen receptor chains. This includes biological mechanisms such as DNA molecular rearrangements in multiple loci (three for IG and four for TR in humans) located on different chromosomes (four in humans), nucleotide deletions and insertions at the rearrangement junctions (or N-diversity), and somatic hypermutations in the IG loci (1,2). IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org) (3), was created in 1989 by Marie-Paule Lefranc, Laboratoire d’ImmunoGénétique Moléculaire LIGM (Université Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and manage the complexity of immunogenetics data. IMGT® has reached that goal through the building of a unique ontology, IMGT-ONTOLOGY (4), the first ontology in immunogenetics and immunoinformatics. IMGT-ONTOLOGY has allowed the setting up of the official nomenclature of the IG and TR genes and alleles (5,6), the definition of IMGT standardized labels, and the IMGT unique numbering that bridges the gap between sequences and 3D structures for the variable (V) and constant (C) domains of the IG and TR (7–10) and for the groove (G) domains of the major histocompatibility complex (MHC) (11). IMGT® is recognized as the global reference that provides the standards in immunogenetics and immunoinformatics. IMGT® is a high-quality integrated knowledge resource, specialized in the IG, TR, MHC of human and other vertebrates, the proteins that belong to the immunoglobulin superfamily (IgSF) and to the MHC superfamily (MhcSF), and the related proteins of the immune systems (RPI) of any species. IMGT® provides a common access to standardized data from genome, proteome, genetics and 3D structures. The IMGT® information system consists of databases, tools and Web resources (3). IMGT® databases include one genome database, several sequence databases and one 3D structure database. Fifteen IMGT® interactive online tools are provided for genome, sequence and 3D structure analysis. IMGT® Web resources comprise more than 10 000 HTML pages of synthesis and knowledge (IMGT Scientific chart, IMGT Repertoire, The IMGT Medical page, The IMGT Veterinary page, The IMGT Biotechnology page, IMGT Education, IMGT Lexique, IMGT Aide-Mémoire, Tutorials, IMGT Index), external links (IMGT Bloc-notes, The IMGT Immunoinformatics page) and IMGT other accesses (SRS, MRS). Despite the heterogeneity of these different components, all data in IMGT® are expertly annotated. The accuracy, the consistency and the integration of the IMGT® data, as well as the coherence between the different IMGT® components (databases, tools and Web resources) are based on the IMGT-ONTOLOGY axioms and concepts (4,12).

IMGT-ONTOLOGY

Formal IMGT-ONTOLOGY

The Formal IMGT-ONTOLOGY, also designated as IMGT Kaleidoscope (12), comprises seven axioms: IDENTIFICATION, DESCRIPTION, CLASSIFICATION, NUMEROTATION, ORIENTATION, LOCALIZATION and OBTENTION that postulate that objects, processes and relations have to be identified, described, classified, numerotated, localized, orientated, and that the way they are obtained has to be determined. IMGT-ONTOLOGY concepts derived from these axioms are available, for the biologists and IMGT® users, in the IMGT Scientific chart, and have been formalized, for the computing scientists, in IMGT-ML which is an XML Schema (http://www.w3.org/TR/xmlschema-0/). In order to formalize the semantic relations between concepts and instances that are essential for high-quality data processing and coherence control, IMGT-ONTOLOGY is currently designed with Protégé (13) and OBO-Edit (http://oboedit.org/).

IMGT Scientific chart

The IMGT Scientific chart is constituted by controlled vocabulary and annotation rules for data and knowledge management of the IG, TR, MHC, IgSF, MhcSF and RPI. All IMGT® data are expertly annotated according to the IMGT Scientific chart rules.

Keywords and labels

IMGT standardized keywords (concepts of identification) are assigned to all entries in the IMGT® databases. More than 500 IMGT standardized labels (concepts of description) were necessary to describe all structural and functional subregions that compose IG and TR (221 labels for sequences and 285 for 3D structures). Interestingly, 64 IMGT specific labels defined for nucleotide sequences have been entered in the newly created Sequence Ontology (SO) (14).

Gene and allele nomenclature

All the human IMGT standardized gene names (5,6) (concepts of classification) were approved by the Human Genome Organisation (HUGO) Nomenclature Committee (HGNC) in 1999 (15), and entered in IMGT/GENE-DB (16), and in Entrez Gene NCBI (17), and more recently on the Ensembl server (18) at the European Bioinformatics Institute (EBI) in 2006, and in the Vega (19) database at the Wellcome Trust Sanger Institute in 2008. All the mouse IMGT® gene and allele names and the corresponding IMGT reference sequences were provided to HGNC and to the Mouse Genome Informatics Mouse Genome Database (20) in July 2002 and were presented by IMGT® at the 19th International Mouse Genome Conference, IMGC 2005, in Strasbourg, France, and entered in IMGT/GENE-DB. IMGT reference sequences have been defined for each allele of each gene based on one or, whenever possible, several of the following criteria: germline sequence, first sequence published, longest sequence, mapped sequence.

IMGT unique numbering

The IMGT unique numbering (concepts of numerotation) (7–11) is, with its 2D graphical representation or IMGT Collier de Perles (21,22), the flagship of IMGT® that allows to bridge the gap between sequences, genes and 3D structures in the IMGT® databases, tools and Web resources (23). Structural and functional domains of the IG and TR chains comprise the V-DOMAIN (9-strand β-sandwich) which corresponds to the V-J-REGION or V-D-J-REGION and is encoded by two or three genes (1,2), and the constant domain or C-DOMAIN (7-strand β-sandwich). The IMGT unique numbering initially defined for the IG and TR domains has been extended to the V-LIKE-DOMAIN and C-LIKE-DOMAIN of IgSF proteins other than IG and TR (9,10,22). The IMGT unique numbering for the MHC G-DOMAIN (four β-strand and one α-helix) has been extended to the G-LIKE-DOMAIN of MhcSF proteins other than MHC (11,22).

IMGT Choreography

In order to extract knowledge from IMGT® standardized immunogenetics data, three main IMGT® biological approaches have been developed: genomic, genetic and structural approaches (Figure 1). The IMGT® genomic approach is gene-centered and mainly orientated towards the study of the genes within their loci and on the chromosomes. The IMGT® genetic approach refers to the study of the genes in relation with their sequence polymorphisms and mutations, their expression, their specificity and their evolution. The IMGT® structural approach refers to the study of the 2D and 3D structures of the IG, TR, MHC, IgSF, MhcSF and RPI, and to the antigen- or ligand-binding characteristics in relationship with the protein functions, polymorphisms and evolution. For each approach, IMGT® provides databases, tools and Web resources (Figure 1 and Table 1). IMGT-Choreography (33), based on the Web service architecture paradigm, has been developed with the goal to enable significant biological and clinical requests involving every part of the IMGT® information system.
Figure 1.

IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org). Genomic, genetic and structural components (databases and tools) are in yellow, green and blue, respectively. The IMGT Repertoire and other Web resources are not shown. Interactions in the genomic, genetic and structural approaches are represented with continuous, dotted and broken lines, respectively.

Table 1.

IMGT® databases, tools and Web resources for genomic, genetic and structural approaches

ApproachesDatabasesToolsWeb resourcesa
GenomicIMGT/GENE-DB (16)IMGT/GeneView IMGT/LocusView IMGT/CloneSearch IMGT/GeneSearch IMGT/GeneInfo (28) IMGT/GeneFrequencyIMGT Repertoire ‘Locus and genes’ section: –chromosomal localizations (1,2) –locus representations (1,2) –locus description –gene tables, etc. –potential germline repertoires –lists of genes –correspondence between nomenclatures (1,2)
GeneticIMGT/LIGM-DB (24) IMGT/PRIMER-DB (25) IMGT/MHC-DB (26)IMGT/V-QUEST (29) IMGT/JunctionAnalysis (30) IMGT/Allele-Align IMGT/PhyloGene (31) IMGT/DomainDisplayIMGT Repertoire ‘Proteins and alleles’ section: –alignments of alleles –protein displays –tables of alleles etc.
StructuralIMGT/3Dstructure-DB (27)IMGT/DomainGapAlign IMGT/Collier-de-Perles IMGT/DomainSuperimpose IMGT/StructuralQuery (27)IMGT Repertoire ‘2D and 3D structures’ section: –IMGT Colliers de Perles (2D representations on one  layer or two layers) (21,22) –IMGT® classes for amino acid characteristics (32) –IMGT Colliers de Perles reference profiles (32) –3D representations

aOnly Web resources examples from the IMGT Repertoire section are shown.

IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org). Genomic, genetic and structural components (databases and tools) are in yellow, green and blue, respectively. The IMGT Repertoire and other Web resources are not shown. Interactions in the genomic, genetic and structural approaches are represented with continuous, dotted and broken lines, respectively. IMGT® databases, tools and Web resources for genomic, genetic and structural approaches aOnly Web resources examples from the IMGT Repertoire section are shown.

IMGT® DATABASES

Gene database

IMGT/GENE-DB (16) is the comprehensive IMGT® genome database. IMGT/GENE-DB is the official repository of all the IG and TR genes and alleles approved by the World Health Organization (WHO)/International Union of Immunological Societies (IUIS) Nomenclature Subcommittee for IG and TR (34,35). In September 2008, IMGT/GENE-DB contained 1911 IG and TR genes from human, mouse and rat and 2909 alleles. Reciprocal links exist between IMGT/GENE-DB and the HGNC database (36) and Entrez Gene (17). IMGT-GENE-DB allows a query per gene and allele name. IMGT/GENE-DB interacts dynamically with IMGT/LIGM-DB (24) to download and display human, mouse and rat gene-related sequence data. This is the first example of an interaction between IMGT® databases using the concepts of classification.

Sequence databases

IMGT/LIGM-DB

IMGT/LIGM-DB (24) is the comprehensive IMGT® database of IG and TR nucleotide sequences from human and other vertebrate species, with translation for fully annotated sequences, created in 1989 by LIGM, Montpellier, France, on the Web since July 1995. IMGT/LIGM-DB is the first and the largest IMGT® database. In September 2008, IMGT/LIGM-DB contained 126 667 nucleotide sequences of IG and TR from 223 vertebrate species. The unique source of data for IMGT/LIGM-DB is EMBL-Bank (18) which shares data with the other two generalist databases GenBank (37) and DDBJ (38). IMGT/LIGM-DB sequence data are identified by the EMBL/GenBank/DDBJ accession number. Based on expert analysis, specific detailed annotations are added to IMGT flat files. The Web interface allows searches according to immunogenetic specific criteria and is easy to use without any knowledge in a computing language. Selection is displayed at the top of the resulting sequences page, so the users can check their own queries. Users have the possibility to modify their request or consult the results with a choice of nine possibilities. The IMGT/LIGM-DB annotations (gene and allele name assignment, labels) allow data retrieval not only from IMGT/LIGM-DB, but also from other IMGT® databases. For example, the IMGT/GENE-DB entries provide the IMGT/LIGM-DB accession numbers of the IG and TR cDNA sequences that contain a given V, D, J or C gene. The automatic annotation of rearranged human and mouse cDNA sequences in IMGT/LIGM-DB is performed by IMGT/Automat (39), an internal Java tool that implements IMGT/V-QUEST (29) and IMGT/JunctionAnalysis (30). IMGT/LIGM-DB data are also distributed by anonymous FTP servers at CINES (ftp://ftp.cines.fr/IMGT/) and EBI (ftp://ftp.ebi.ac.uk/pub/databases/imgt/) and from several Sequence Retrieval System (SRS) sites. IMGT/LIGM-DB can be searched by BLAST or FASTA on different servers (EBI, IGH, Institut Pasteur Paris).

Other IMGT sequence databases

IMGT/PRIMER-DB (25) is the IMGT® oligonucleotide database on the Web since February 2002. In September 2008, IMGT/PRIMER-DB contained 1864 entries. The database manages standardized information on oligonucleotides (or Primers) and combinations of primers (Sets and Couples) for IG and TR. These primers are useful for combinatorial library constructions, scFv, phage display or microarray technologies. IMGT/PROTEIN-DB, in developement, will contain the translations of the IMGT/LIGM-DB and IMGT/GENE-DB sequences. IMGT/MHC-DB hosted at EBI comprises IMGT/HLA for human MHC (or HLA) and IMGT/MHC-NHP, for MHC of non-human primates (26).

Structure database

IMGT/3Dstructure-DB is the IMGT® 3D structure database, created by LIGM, on the Web since November 2001 (27). IMGT/3Dstructure-DB comprises IG, TR, MHC, IgSF, MhcSF and RPI with known 3D structures. In September 2008, IMGT/3Dstructure-DB contained 1461 atomic coordinate files. These coordinate files extracted from the Protein Data Bank (PDB) (http://www.rcsb.org/pdb/) (40) are renumbered according to the standardized IMGT unique numbering (9–11). The IMGT/3Dstructure-DB cards provide chain details with IMGT annotations (receptor, chain and domain description with IMGT labels, assignment of IMGT gene and allele names, domain delimitations and amino acid positions according to the IMGT unique numbering, and IMGT Colliers de Perles on one layer and two layers), contact analysis, downloadable renumbered IMGT/3Dstructure-DB flat files, visualization tools (Jmol and QuickPDB), and external links. IMGT Residue@Position cards provide detailed information on the inter- and intra-domain contacts at each residue position, based on the IMGT unique numbering. The contacts are described per domain (intra- and inter-domain contacts) and annotated in terms of IMGT® labels (chain and domain), positions (IMGT unique numbering), backbone or side-chain implication.

IMGT® TOOLS

Gene tools

The IMGT® gene tools (genomic approach) manage the locus organization and gene location and provide the display of physical maps for the human and mouse IG, TR and MHC loci. They allow to view genes in a locus (IMGT/GeneView, IMGT/LocusView), to search for clones (IMGT/CloneSearch), or to search for genes in a locus (IMGT/GeneSearch, IMGT/GeneInfo) based on IMGT® gene names, functionality or localization on the chromosome. IMGT/GeneFrequency provides a graphical representation of the numbers of cDNA and gDNA IMGT/LIGM-DB sequences containing rearranged IG and TR genes.

Sequence tools

The IMGT® sequence analysis tools (genetic approach) comprise IMGT/V-QUEST (29) for the identification of the V, D and J genes and of their mutations, IMGT/JunctionAnalysis (30) for the analysis of the V-J and V-D-J junctions that confer the antigen receptor specificity, IMGT/Allele-Align for the detection of polymorphisms, IMGT/Phylogene (31) for gene evolution analyses, and IMGT/DomainDisplay for the display of amino acid sequences from the IMGT domain directory. IMGT/V-QUEST (V-QUEry and STandardization) (29) is an integrated software for IG and TR. This tool, which is easy to use, analyses an input of up to fifty IG or TR germline or rearranged variable nucleotide sequences. IMGT/V-QUEST results comprise, for rearranged sequences, the identification of the V, D and J genes and alleles, nucleotide alignments by comparison with the IMGT reference directory, the delimitations of the framework regions (FR-IMGT) and complementarity determining regions (CDR-IMGT) based on the IMGT unique numbering, the protein translation of the input sequences, the result of IMGT/JunctionAnalysis, the description of the mutations and amino acid changes of the V-REGION and the IMGT Collier de Perles representation of the V-DOMAIN.

Structure tools

The IMGT® structure tools bridge the gap between sequences and 3D structures: IMGT/DomainGapAlign analyses amino acid sequences per domain, IMGT/Collier-de-Perles allows to make your own IMGT Collier de Perles, and IMGT/DomainSuperimpose allows to superimpose two domain 3D structures from IMGT/3Dstructure-DB. IMGT/StructuralQuery (27) allows to retrieve the IMGT/3Dstructure-DB entries containing a V-DOMAIN, based on specific structural characteristics of the intramolecular interactions: phi and psi angles, accessible surface area, amino acid type, distance in angstrom between amino acids, and CDR-IMGT lengths.

IMGT® WEB RESOURCES

IMGT Repertoire

The IMGT® Web resources for genomic, genetic and structural approaches are compiled in the sections of the IMGT Repertoire and provide a synthetic view of data managed in the databases and tools.

Genomics Web resources

The IMGT® genomics resources are compiled in the ‘Locus and genes’ section which includes ‘Chromosomal localizations’, ‘Locus representations’, ‘Locus description’, ‘Gene exon/intron organization’, ‘Gene exon/intron splicing sites’, ‘Gene tables’, ‘Potential germline repertoires’, lists of IG and TR genes and links between IMGT®, HGNC, Entrez Gene and OMIM, and correspondence between nomenclatures (1,2). The IMGT Repertoire ‘Probes and RFLP’ section provides data on gene insertion/deletion.

Genetics Web resources

The IMGT® genetics resources are compiled in the ‘Proteins and alleles’ section which includes ‘Alignments of alleles’, ‘Tables of alleles’, ‘Allotypes’, ‘Isotypes’, ‘Protein displays’, etc.

Structural Web resources

The IMGT® structural resources are compiled in the ‘2D and 3D structures’ section which includes IMGT Colliers de Perles (21,22), FR-IMGT and CDR-IMGT lengths, amino acid chemical characteristics profiles (32). To appropriately analyse the amino acid resemblances and differences between IG, TR, MHC and RPI chains, eleven IMGT classes were defined for the amino acid ‘chemical characteristics’ properties and used to set up IMGT Colliers de Perles references profiles. IMGT Colliers de Perles reference profiles allow to easily compare amino acid properties at each position whatever the domain, the chain, the receptor or the species. The visualization of 3D representations of IG and TR variable domains allows rapid correlation between protein sequences and 3D data.

Other Web resources

In addition to the IMGT Scientific chart and IMGT Repertoire, other major components of the IMGT® Web resources comprise The IMGT Medical page, The IMGT Veterinary page, The IMGT Biotechnology page, IMGT Education, IMGT Lexique, IMGT Aide-Mémoire, Tutorials, IMGT Index, and external links (IMGT Bloc-notes, The IMGT Immunoinformatics page, Interesting links) and IMGT other accesses (SRS,MRS).

CONCLUSION

Since July 1995, IMGT® has been available on the Web at the IMGT Home page http://www.imgt.org (Montpellier, France). IMGT® has an exceptional response with more than 150 000 requests a month. The information is of much value to clinicians and biological scientists in general. IMGT® databases, tools, and Web resources are extensively queried and used by scientists from both academic and industrial laboratories, who are equally distributed between the United States, Europe and the remaining world. IMGT® is used in very diverse domains: (i) fundamental and medical research (repertoire analysis of the IG antibody recognition sites and of the TR recognition sites in normal and pathological situations such as autoimmune diseases, infectious diseases, AIDS, leukemias, lymphomas and myelomas); (ii) veterinary research (IG and TR repertoires in farm and wild life species); (iii) genome diversity and genome evolution studies of the adaptive immune responses; (iv) structural evolution of the IgSF and MhcSF proteins; (v) biotechnology related to antibody engineering (single chain Fragment variable (scFv), phage displays, combinatorial libraries, chimeric, humanized and human antibodies); (vi) diagnostics (clonalities, detection and follow-up of residual diseases) and (vii) therapeutical approaches (grafts, immunotherapy and vaccinology). The creation of dynamic interactions between the IMGT® databases and tools, using Web services and IMGT-ML, and the design of IMGT-Choreography, represent novel and major developments of IMGT®, the international reference in immunogenetics and immunoinformatics.

CITING IMGT

Users are requested to cite this article and quote the IMGT home page URL, http://www.imgt.org.

FUNDING

The BIOMED1 (BIOCT930038), Biotechnology BIOTECH2 (BIO4CT960037) and 5th PCRDT Quality of Life and Management of Living Resources programmes (QLG2-2000-01287) programmes of the European Union (EU). IMGT® is currently supported by the CNRS, the Ministère de l’Enseignement Supérieur et de la Recherche (MESR) (Université Montpellier 2 Plan Pluri-Formation, Institut Universitaire de France), Réseau National des Génopoles, the Région Languedoc-Roussillon, the Agence Nationale de la recherche ANR (BIOSYS06_135457, FLAVORES), and the EU ImmunoGrid (IST-028069). Funding for open access charge: CNRS. Conflict of interest statement. None declared.
  34 in total

1.  Guidelines for human gene nomenclature.

Authors:  Hester M Wain; Elspeth A Bruford; Ruth C Lovering; Michael J Lush; Mathew W Wright; Sue Povey
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

2.  IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains.

Authors:  Marie-Paule Lefranc; Christelle Pommié; Quentin Kaas; Elodie Duprat; Nathalie Bosc; Delphine Guiraudou; Christelle Jean; Manuel Ruiz; Isabelle Da Piédade; Mathieu Rouard; Elodie Foulquier; Valérie Thouvenin; Gérard Lefranc
Journal:  Dev Comp Immunol       Date:  2005       Impact factor: 3.636

3.  WHO-IUIS Nomenclature Subcommittee for immunoglobulins and T cell receptors report August 2007, 13th International Congress of Immunology, Rio de Janeiro, Brazil.

Authors:  Marie-Paule Lefranc
Journal:  Dev Comp Immunol       Date:  2007-11-06       Impact factor: 3.636

Review 4.  IMGT, a system and an ontology that bridge biological and computational spheres in bioinformatics.

Authors:  Marie-Paule Lefranc; Véronique Giudicelli; Laetitia Regnier; Patrice Duroux
Journal:  Brief Bioinform       Date:  2008-04-19       Impact factor: 11.622

5.  Entrez Gene: gene-centered information at NCBI.

Authors:  Donna Maglott; Jim Ostell; Kim D Pruitt; Tatiana Tatusova
Journal:  Nucleic Acids Res       Date:  2006-12-05       Impact factor: 16.971

6.  IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.

Authors:  Véronique Giudicelli; Denys Chaume; Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

7.  GenBank.

Authors:  Dennis A Benson; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; David L Wheeler
Journal:  Nucleic Acids Res       Date:  2007-12-11       Impact factor: 16.971

8.  Priorities for nucleotide trace, sequence and annotation data capture at the Ensembl Trace Archive and the EMBL Nucleotide Sequence Database.

Authors:  Guy Cochrane; Ruth Akhtar; Philippe Aldebert; Nicola Althorpe; Alastair Baldwin; Kirsty Bates; Sumit Bhattacharyya; James Bonfield; Lawrence Bower; Paul Browne; Matias Castro; Tony Cox; Fehmi Demiralp; Ruth Eberhardt; Nadeem Faruque; Gemma Hoad; Mikyung Jang; Tamara Kulikova; Alberto Labarga; Rasko Leinonen; Steven Leonard; Quan Lin; Rodrigo Lopez; Dariusz Lorenc; Hamish McWilliam; Gaurab Mukherjee; Francesco Nardone; Sheila Plaister; Stephen Robinson; Siamak Sobhany; Robert Vaughan; Dan Wu; Weimin Zhu; Rolf Apweiler; Tim Hubbard; Ewan Birney
Journal:  Nucleic Acids Res       Date:  2007-11-26       Impact factor: 16.971

9.  The vertebrate genome annotation (Vega) database.

Authors:  L G Wilming; J G R Gilbert; K Howe; S Trevanion; T Hubbard; J L Harrow
Journal:  Nucleic Acids Res       Date:  2007-11-14       Impact factor: 16.971

10.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis.

Authors:  Xavier Brochet; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Nucleic Acids Res       Date:  2008-05-24       Impact factor: 16.971

View more
  346 in total

1.  Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.

Authors:  Kwan-Ki Hwang; Xi Chen; Daniel M Kozink; Marietta Gustilo; Dawn J Marshall; John F Whitesides; Hua-Xin Liao; Rosa Catera; Charles C Chu; Xiao-Jie Yan; Micah A Luftig; Barton F Haynes; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-12-12       Impact factor: 22.113

2.  Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.

Authors:  Marie Pancera; Jason S McLellan; Xueling Wu; Jiang Zhu; Anita Changela; Stephen D Schmidt; Yongping Yang; Tongqing Zhou; Sanjay Phogat; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

Review 3.  Rep-Seq: uncovering the immunological repertoire through next-generation sequencing.

Authors:  Jennifer Benichou; Rotem Ben-Hamo; Yoram Louzoun; Sol Efroni
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

Review 4.  Immunoinformatics: an integrated scenario.

Authors:  Namrata Tomar; Rajat K De
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

5.  Copy number variation and association over T-cell receptor genes--influence of DNA source.

Authors:  Christine Schwienbacher; Alessandro De Grandi; Christian Fuchsberger; Maurizio F Facheris; Mirija Svaldi; Matthias Wjst; Peter P Pramstaller; Andrew A Hicks
Journal:  Immunogenetics       Date:  2010-06-26       Impact factor: 2.846

6.  Immune responses are characterized by specific shared immunoglobulin peptides that can be detected by proteomic techniques.

Authors:  Martijn M VanDuijn; Lennard J M Dekker; L Zeneyedpour; Peter A E Sillevis Smitt; Theo M Luider
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

7.  Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

Authors:  Charles C Chu; Lu Zhang; Arjun Dhayalan; Briana M Agagnina; Amanda R Magli; Gia Fraher; Sebastien Didier; Linda P Johnson; William J Kennedy; Rajendra N Damle; Xiao-Jie Yan; Piers E M Patten; Saul Teichberg; Prasad Koduru; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

8.  Structural and comparative analysis of the T cell receptor gamma (TRG) locus in Oryctolagus cuniculus.

Authors:  Serafina Massari; Salvatrice Ciccarese; Rachele Antonacci
Journal:  Immunogenetics       Date:  2012-07-07       Impact factor: 2.846

9.  Cynomolgus and pigtail macaque IgG subclasses: characterization of IGHG genes and computational analysis of IgG/Fc receptor binding affinity.

Authors:  Doan C Nguyen; Rashesh Sanghvi; Franco Scinicariello; Joanna Pulit-Penaloza; Nicole Hill; Roberta Attanasio
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

10.  Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes.

Authors:  Karen Cerosaletti; Fariba Barahmand-Pour-Whitman; Junbao Yang; Hannah A DeBerg; Matthew J Dufort; Sara A Murray; Elisabeth Israelsson; Cate Speake; Vivian H Gersuk; James A Eddy; Helena Reijonen; Carla J Greenbaum; William W Kwok; Erik Wambre; Martin Prlic; Raphael Gottardo; Gerald T Nepom; Peter S Linsley
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.